Disease mechanisms in inherited neuropathies

被引:269
作者
Suter, U [1 ]
Scherer, SS
机构
[1] ETH Honggerberg, Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland
[2] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nrn1196
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Inherited neuropathies are caused by dominant or recessive mutations in genes that are expressed by neurons and/ or Schwann cells. In demyelinating neuropathies, the deleterious effects originate primarily in myelinating Schwann cells. In axonal neuropathies, neurons ( axons) are initially affected. In demyelinating neuropathies, the axonal cytoskeleton is altered and axonal transport is disrupted. In some axonal neuropathies, genes that are directly involved in axonal transport are mutated. So, a common consequence of inherited neuropathies is disruption of the ability of neurons to transport cargo efficiently along the entire length of their axons. These findings correlate with the observations that axonal atrophy and/ or loss are primarily responsible for the clinical disability in hereditary neuropathies.
引用
收藏
页码:714 / 726
页数:13
相关论文
共 152 条
[1]   Mutations in connexin 32: the molecular and biophysical bases for the X-linked form of Charcot-Marie-Tooth disease [J].
Abrams, CK ;
Oh, S ;
Ri, Y ;
Bargiello, TA .
BRAIN RESEARCH REVIEWS, 2000, 32 (01) :203-214
[2]  
Adlkofer K, 1997, J NEUROSCI RES, V49, P671, DOI 10.1002/(SICI)1097-4547(19970915)49:6<671::AID-JNR2>3.0.CO
[3]  
2-4
[4]  
Adlkofer K, 1997, J NEUROSCI, V17, P4662
[5]   HYPERMYELINATION AND DEMYELINATING PERIPHERAL NEUROPATHY IN PMP22-DEFICIENT MICE [J].
ADLKOFER, K ;
MARTINI, R ;
AGUZZI, A ;
ZIELASEK, J ;
TOYKA, KV ;
SUTER, U .
NATURE GENETICS, 1995, 11 (03) :274-280
[6]   ABNORMAL MYELINATION IN TRANSPLANTED TREMBLER MOUSE SCHWANN-CELLS [J].
AGUAYO, AJ ;
ATTIWELL, M ;
TRECARTEN, J ;
PERKINS, S ;
BRAY, GM .
NATURE, 1977, 265 (5589) :73-75
[7]   Neurofilaments and neurological disease [J].
Al-Chalabi, A ;
Miller, CCJ .
BIOESSAYS, 2003, 25 (04) :346-355
[8]  
Altevogt BM, 2002, J NEUROSCI, V22, P6458
[9]   Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V [J].
Antonellis, A ;
Ellsworth, RE ;
Sambuughin, N ;
Puls, I ;
Abel, A ;
Lee-Lin, SQ ;
Jordanova, A ;
Kremensky, I ;
Christodoulou, K ;
Middleton, LT ;
Sivakumar, K ;
Ionasescu, V ;
Funalot, B ;
Vance, JM ;
Goldfarb, LG ;
Fischbeck, KH ;
Green, ED .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (05) :1293-1299
[10]  
Anzini P, 1997, J NEUROSCI, V17, P4545